Concepedia

Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress

Mahmoud El‐Daly, Vivek Krishna Pulakazhi Venu, Mahmoud Saifeddine, Koichiro Mihara, Sean Kang, Paul W.M. Fedak, Laurie Alston, Simon A. Hirota, Hong Ding, Chris R. Triggle,

Vascular Pharmacology · 2018 · 115 citations · 54 references

DOI

Concepts

References

54

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

Stephen A. Bustin, Vladimı́r Beneš, Jeremy A. Garson et al. · Clinical Chemistry · 2009 · 16.1K citations · Full text

, , +12

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text

, , +15

Biochemistry and molecular cell biology of diabetic complications

Michael Brownlee · Nature · 2001 · 9K citations

, , +14

Animal research: Reporting <i>in vivo</i> experiments: The ARRIVE guidelines

Carol Kilkenny, William J. Browne, Innes C. Cuthill et al. · British Journal of Pharmacology · 2010 · 3.6K citations · Full text

, , +16

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

Albena T. Dinkova‐Kostova, W. David Holtzclaw, Robert N. Cole et al. · Proceedings of the National Academy of Sciences · 2002 · 1.9K citations · Full text

, , +16